Despite advancements in the management of pediatric ALL (B-cell and T-cell ALL), that have occurred, the incidence of the disease has exhibited an increasing trend ( 3 ).
← all excerpts
Potential therapeutic targets and small molecular drugs for pediatric B-precursor acute lymphoblastic leukemia treatment based on microarray data.
1
—
—